ArticleJAC-antimicrobial resistance2026
Impact of medium composition on cefiderocol susceptibility testing: comparison of CLSI/EUCAST-compliant and commercial broth microdilution methods.
Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Cefiderocol is a siderophore cephalosporin active against multidrug-resistant Gram-negative bacteria. However, accurate cefiderocol MIC determination remains challenging due to methodological variability. This study investigated whether differences between a CLSI/EUCAST-compliant in-house BMD method and the commercial UMIC system influence MIC determination and susceptibility interpretation. Methods: A total of 119 clinical isolates, including 44 Results: For isolates with DDT zones <21 mm, in-house BMD classified 35 isolates as susceptible and 27 as resistant, whereas UMIC classified 31 as susceptible and 31 as resistant. Isolates with DDT zones within the EUCAST area of technical uncertainty (ATU, 21-23 mm) and ≥24 mm showed high categorical concordance across MIC methods. Overall categorical agreement and essential agreement between the in-house BMD method and the commercial UMIC system were 81.5% and 60.5%, respectively. In-house BMD MICs clustered at 1-4 mg/L, whereas UMIC MICs showed broader distributions. These findings coincided with differences in calcium, magnesium and zinc concentrations. Conclusions: Method-dependent variability in cefiderocol MIC determination may affect susceptibility interpretation near clinical breakpoints. Differences in testing conditions, particularly medium composition, may contribute to the observed differences. DDT showed good categorical concordance with both BMD methods for clearly susceptible isolates.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.